Xudan Wang
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Interference and Gene Delivery
Papers in
- Surgery 3
- Hydrogen's biological and therapeutic effects 1
- Co-authors
- Ruiying Zhao (1 shared paper)Huiling Yang (1 shared paper)Rong Zhang (1 shared paper)Zhihui Liang (1 shared paper)Changju Qu (1 shared paper)Sumei Wang (1 shared paper)Mong‐Hong Lee (1 shared paper)Jia-Ling Huang (1 shared paper)
- Journals
- Journal of Hepatology (2 papers)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (1 paper)Frontiers in Oncology (1 paper)Frontiers in Bioengineering and Biotechnology (1 paper)Applied Biochemistry and Biotechnology (1 paper)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Xudan Wang
12 papers receiving 329 citations
Xudan Wang's Hit Papers
Peers
Comparison fields: 5 of 56
- Cancer Research 149
- Molecular Biology 173
- Rehabilitation 14
- Oncology 32
- Physiology 30
Countries citing papers authored by Xudan Wang
This map shows the geographic impact of Xudan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xudan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xudan Wang more than expected).
Fields of papers citing papers by Xudan Wang
This network shows the impact of papers produced by Xudan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xudan Wang. The network helps show where Xudan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xudan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 155 | |
| 2 | Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis via RNA splicing regulation of MADD Hit paper breakdown → | 2024 | 70 |
| 3 | 2015 | 21 | |
| 4 | 2014 | 20 | |
| 5 | 2022 | 18 | |
| 6 | 2021 | 18 | |
| 7 | 2018 | 13 | |
| 8 | 2022 | 7 | |
| 9 | 2025 | 3 | |
| 10 | 2023 | 2 | |
| 11 | 2024 | 2 | |
| 12 | 2022 | 1 | |
| 13 | 2024 | 0 |
About Xudan Wang
Xudan Wang is a scholar working on Surgery, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Hepatology, having authored 13 papers that have together received 330 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Hydrogen's biological and therapeutic effects (1 paper), Electrospun Nanofibers in Biomedical Applications (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Immunotherapy and Immune Responses (1 paper), Wound Healing and Treatments (1 paper) and Biochemical effects in animals (1 paper). The work is most often cited by research in Cancer Research (149 citations), Molecular Biology (173 citations), Rehabilitation (14 citations), Oncology (32 citations) and Physiology (30 citations). Xudan Wang has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Ruiying Zhao, Huiling Yang, Rong Zhang, Zhihui Liang, Changju Qu, Sumei Wang, Mong‐Hong Lee, Jia-Ling Huang, Kaishan Tao and Rui Jiang. Their work appears in journals such as Journal of Hepatology, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Frontiers in Oncology, Frontiers in Bioengineering and Biotechnology and Applied Biochemistry and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.